{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:08:44Z","timestamp":1793830124259,"version":"4.6.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Clinical trials need to include patients who are representative of the population who may receive the tested interventions in the future. The importance of inclusivity is recognised by ethical and funding bodies and has public support. Appropriate inclusion is required to provide equitable evidence-based healthcare and to comply with ethical principles for research. However, there is little information about the inclusivity of most under-served groups in UK clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This audit assesses the inclusion of under-served groups in trials run by the Oxford Primary Care Clinical Trials Unit (PC-CTU). We included trials with ethical approval between 2017 and 2023. We checked protocols, patient-facing information and selected data collection tools for information on the under-served groups in the INCLUDE guidance and protected characteristics in the UK Equality Act 2010, to identify explicit exclusions and data collection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 19 trials. They were in a variety of clinical conditions, testing different types of interventions, both Clinical Trial of an Investigational Medicinal Product (CTIMP) and non-CTIMP. Most were non-commercially funded. We reviewed 21 protocols, 29 Patient Information Sheets\/Leaflets and 40 data collection tools.<\/jats:p>\n                    <jats:p>Common exclusions were based on age (19), sex or gender (11), language (8), capacity to consent (14), pregnancy (11), multiple health conditions (10) and severity of illness (17).<\/jats:p>\n                    <jats:p>Trials most often collected data on age (19), sex or gender (15), ethnicity (16), education (11), address (13), mental health conditions (6), who gave consent (19), addiction (6), multiple health conditions (10), severity of illness (17), smoking status (12) and obesity (13).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Often, exclusions were due to the focusing of the trial for a specific group, such as older people, women, or people being treated for a specific severity of condition. However, many explicit exclusions may not have been essential, may have reduced the inclusivity of the trials and might limit the applicability of the trial\u2019s findings to people to whom the tested interventions might be relevant. These include the exclusion of people aged under 18, people without English language fluency and people without capacity to consent. All trials could have collected more informative data on under-served group status.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-025-08893-9","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T11:30:48Z","timestamp":1750505448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Inclusion of under-served groups in trials: an audit at a UK primary care clinical trials unit"],"prefix":"10.1186","volume":"26","author":[{"given":"Rebekah","family":"Burrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2926-7257","authenticated-orcid":false,"given":"Mike","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"key":"8893_CR1","unstructured":"MBRRACE-UK. Saving Lives, Improving Mothers' Care - Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2019\u201321. 2023.\u00a0https:\/\/www.npeu.ox.ac.uk\/mbrrace-uk. Accessed 14 May 2025."},{"issue":"31","key":"8893_CR2","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1093\/eurheartj\/ehab457","volume":"42","author":"J van Diemen","year":"2021","unstructured":"van Diemen J, Verdonk P, Chieffo A, Regar E, Mauri F, Kunadian V, et al. The importance of achieving sex- and gender-based equity in clinical trials: a call to action. Eur Heart J. 2021;42(31):2990\u20134.","journal-title":"Eur Heart J"},{"issue":"10242","key":"8893_CR3","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/S0140-6736(20)31380-5","volume":"395","author":"S Treweek","year":"2020","unstructured":"Treweek S, Forouhi NG, Narayan KMV, Khunti K. COVID-19 and ethnicity: who will research results apply to? The Lancet. 2020;395(10242):1955\u20137.","journal-title":"The Lancet"},{"key":"8893_CR4","doi-asserted-by":"publisher","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Participants. JAMA. 2025;333(1):71\u20134. https:\/\/doi.org\/10.1001\/jama.2024.21972.","DOI":"10.1001\/jama.2024.21972"},{"issue":"1","key":"8893_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12916-023-02809-7","volume":"21","author":"M Murali","year":"2023","unstructured":"Murali M, Gumber L, Jethwa H, Ganesh D, Hartmann-Boyce J, Sood H, et al. Ethnic minority representation in UK COVID-19 trials: systematic review and meta-analysis. BMC Med. 2023;21(1):111.","journal-title":"BMC Med"},{"key":"8893_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n513","volume":"372","author":"MS Razai","year":"2021","unstructured":"Razai MS, Osama T, McKechnie DGJ, Majeed A. Covid-19 vaccine hesitancy among ethnic minority groups. BMJ. 2021;372: n513.","journal-title":"BMJ"},{"key":"8893_CR7","unstructured":"Office for National Statistics. Coronavirus (COVID-19) case rates by socio-demographic characteristics, England: 1 September 2020 to 10 December 2021. Office for National Statistics.\u00a0United Kingdom: Office for National Statistics; 2022.\u00a0https:\/\/service-manual.ons.gov.uk\/content\/formatting-and-punctuation\/citations-references-and-sources."},{"issue":"3","key":"8893_CR8","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.1016\/S2214-109X(20)30484-8","volume":"9","author":"MM Taylor","year":"2021","unstructured":"Taylor MM, Kobeissi L, Kim C, Amin A, Thorson AE, Bellare NB, et al. Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action. Lancet Glob Health. 2021;9(3):e366\u201371.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"8893_CR9","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1038\/s41467-024-47181-z","volume":"15","author":"HM Engjom","year":"2024","unstructured":"Engjom HM, Ramakrishnan R, Vousden N, Bunch K, Morris E, Simpson N, et al. Perinatal outcomes after admission with COVID-19 in pregnancy: a UK national cohort study. Nat Commun. 2024;15(1):3234.","journal-title":"Nat Commun"},{"key":"8893_CR10","unstructured":"NHS Health Research Authority. We make it easy to do research that people can trust Strategy 2022\u201325. NHS Health Research Authority. 2023.https:\/\/s3.eu-west-2.amazonaws.com\/www.hra.nhs.uk\/media\/documents\/HRA_Strategy_2022-25.pdf.\u00a0Accessed 14 May 2025."},{"key":"8893_CR11","unstructured":"NIHR. Equality, Diversity and Inclusion Strategy 2022\u20132027.\u00a0NIHR. 2022.\u00a0https:\/\/www.nihr.ac.uk\/documents\/equality-diversity-and-inclusion-strategy-2022-2027\/31295.\u00a0Accessed 14 May 2025."},{"key":"8893_CR12","unstructured":"Innovation URa. UKRI Strategy 2022\u20132027 Transforming tomorrow together.\u00a0UK Research and Innovation. 2022.\u00a0https:\/\/www.ukri.org\/publications\/ukri-strategy-2022-to-2027\/.\u00a0Accessed 14 May 2025."},{"key":"8893_CR13","unstructured":"NHS Health Research Authority. Public Perceptions of Research.\u00a0NHS Health Research Authority. 2023.\u00a0https:\/\/www.hra.nhs.uk\/planning-and-improving-research\/best-practice\/public-perceptions-research\/.\u00a0Accessed 14 May 2025."},{"key":"8893_CR14","unstructured":"NHS Race & Health Observatory. Ethnic Inequalities in Healthcare: A Rapid Evidence Review.\u00a02022.\u00a0https:\/\/www.manchester.ac.uk\/discover\/news\/review-highlights-stark-ethnic-healthcare-inequalities-in-the-uk\/.\u00a0Accessed 14 May 2025."},{"key":"8893_CR15","unstructured":"Swords B, Sheni R. Systemic change required. Black lived reality: why we need systemic change. Black Equity Organisation. 2022. https:\/\/blackequityorg.com\/wpcontent\/uploads\/2022\/09\/Systemic-change-required-V10.pdf. Accessed 6 June 2025."},{"key":"8893_CR16","unstructured":"Equality Act 2010, 2010.\u00a0https:\/\/www.legislation.gov.uk\/ukpga\/2010\/15\/section\/4. Accessed 6 June 2025."},{"key":"8893_CR17","unstructured":"National Institute for Health Research. Improving inclusion of under-served groups in clinical research: Guidance from the NIHR-INCLUDE project. UK. 2022. https:\/\/www.nihr.ac.uk\/documents\/improving-inclusion-of-under-served-groups-in-clinical-researchguidance-from-include-project\/25435. Accessed 6 June 2025."},{"key":"8893_CR18","unstructured":"NIHR. Randomised controlled trial participants: Diversity data report.\u00a02022.\u00a0https:\/\/www.nihr.ac.uk\/documents\/randomised-controlled-trial-participants-diversity-data-report\/31969?pr. Accessed 14 May 2025."},{"issue":"1","key":"8893_CR19","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1186\/s13063-022-06553-w","volume":"23","author":"S Dawson","year":"2022","unstructured":"Dawson S, Banister K, Biggs K, Cotton S, Devane D, Gardner H, et al. Trial Forge Guidance 3: randomised trials and how to recruit and retain individuals from ethnic minority groups\u2014practical guidance to support better practice. Trials. 2022;23(1):672.","journal-title":"Trials"},{"issue":"1","key":"8893_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13063-025-08769-y","volume":"26","author":"GA Alarc\u00f3n Garavito","year":"2025","unstructured":"Alarc\u00f3n Garavito GA, Gilchrist K, Ciurtin C, Khanna S, Chambers P, McNally N, et al. Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review. Trials. 2025;26(1):65.","journal-title":"Trials"},{"issue":"2","key":"8893_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1161\/STROKEAHA.120.033227","volume":"52","author":"C Carcel","year":"2021","unstructured":"Carcel C, Reeves M. Under-Enrollment of Women in Stroke Clinical Trials. Stroke. 2021;52(2):452\u20137.","journal-title":"Stroke"},{"issue":"9","key":"8893_CR22","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1177\/13524585231189670","volume":"29","author":"M Finlayson","year":"2023","unstructured":"Finlayson M, Al-Mashita L, Sandhu R. Participant diversity in clinical trials of rehabilitation interventions for people with multiple sclerosis: A scoping review. Mult Scler J. 2023;29(9):1149\u201357.","journal-title":"Mult Scler J"},{"issue":"3","key":"8893_CR23","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/rheumatology\/kead257","volume":"63","author":"A Ma\u0144ko","year":"2023","unstructured":"Ma\u0144ko A, Raczkiewicz A, G\u00f3rski A, Borysowski J, Wiland P. Exclusion of older adults from randomized controlled trials in rheumatoid arthritis. Rheumatology. 2023;63(3):672\u20139.","journal-title":"Rheumatology"},{"issue":"16","key":"8893_CR24","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1097\/01.aids.0000189866.67182.f7","volume":"19","author":"M Gandhi","year":"2005","unstructured":"Gandhi M, Ameli N, Bacchetti P, Sharp GB, French AL, Young M, et al. Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols. AIDS. 2005;19(16):1885\u201396.","journal-title":"AIDS"},{"issue":"1","key":"8893_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12910-023-00987-w","volume":"24","author":"D Patel","year":"2023","unstructured":"Patel D, Kilburn L, Fox L, Hall E, Bliss J, Lewis R. Equality, diversity, and inclusion in oncology clinical trials: an audit of essential documents and data collection against INCLUDE under-served groups in a UK academic trial setting. BMC Med Ethics. 2023;24(1):105.","journal-title":"BMC Med Ethics"},{"key":"8893_CR26","unstructured":"University of Oxford. Primary Care Clinical Trials Unit.\u00a0University of Oxford. 2024.https:\/\/www.phc.ox.ac.uk\/research\/institutes-units\/phctrials."},{"key":"8893_CR27","unstructured":"UKCRC CTU Network. UKCRC Registered CTU Network https:\/\/ukcrc-ctu.org.uk\/2024."},{"key":"8893_CR28","unstructured":"MESSAGE Writing Group WA, Woodward M, Jenkins K, Jenkins B, Hockham C, Peters S, Politis M, Cooper L, Pow R, Norton R & Womersley K. . Accounting for sex and gender in biomedical, health and care research: A policy framework for research funders. Medical Science Sex and Gender Equity. 2024."},{"key":"8893_CR29","doi-asserted-by":"publisher","unstructured":"Goodwin VA, Low MSA, Quinn TJ, Cockcroft EJ, Shepherd V, Evans PH, et al. Including older people in health and social care research: best practice recommendations based on the INCLUDE framework. Age and Ageing. 2023;52(6):afad082.\u00a0https:\/\/doi.org\/10.1093\/ageing\/afad082.","DOI":"10.1093\/ageing\/afad082"},{"issue":"5","key":"8893_CR30","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1159\/000511889","volume":"237","author":"N Price Kyla","year":"2020","unstructured":"Price Kyla N, Lyons Alexis B, Hamzavi Iltefat H, Hsiao Jennifer L, Shi VY. Facilitating Clinical Trials Participation of Low Socioeconomic Status Patients. Dermatology. 2020;237(5):843\u20136.","journal-title":"Dermatology"},{"issue":"1","key":"8893_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13063-024-07944-x","volume":"25","author":"V Shepherd","year":"2024","unstructured":"Shepherd V, Joyce K, Lewis A, Flynn S, Clout M, Nocivelli B, et al. Improving the inclusion of an under-served group in trials: development and implementation of the INCLUDE Impaired Capacity to Consent Framework. Trials. 2024;25(1):83.","journal-title":"Trials"},{"key":"8893_CR32","doi-asserted-by":"crossref","unstructured":"Edelman NL. Trauma and resilience informed research principles and practice: A framework to improve the inclusion and experience of disadvantaged populations in health and social care research. J Health Serv Res Policy. 2023;28(1):66\u201375.\u00a0Accessed 14 May 2025.","DOI":"10.1177\/13558196221124740"},{"key":"8893_CR33","doi-asserted-by":"crossref","unstructured":"Biggs K, Hullock K, Dix C, Lane JA, Green H, Treweek S, et al. Time to STEP UP: methods and findings from the development of guidance to help researchers design inclusive clinical trials. BMC Med Res Methodol. 2024;24(1):227.\u00a0Accessed 14 May 2025.","DOI":"10.1186\/s12874-024-02342-y"},{"issue":"1","key":"8893_CR34","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/1745-6215-15-399","volume":"15","author":"P Bower","year":"2014","unstructured":"Bower P, Brueton V, Gamble C, Treweek S, Smith CT, Young B, et al. Interventions to improve recruitment and retention in clinical trials: a survey and workshop to assess current practice and future priorities. Trials. 2014;15(1):399.","journal-title":"Trials"},{"issue":"1","key":"8893_CR35","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1186\/s13063-021-05849-7","volume":"22","author":"DH Bodicoat","year":"2021","unstructured":"Bodicoat DH, Routen AC, Willis A, Ekezie W, Gillies C, Lawson C, et al. Promoting inclusion in clinical trials-a rapid review of the literature and recommendations for action. Trials. 2021;22(1):880.","journal-title":"Trials"},{"issue":"1","key":"8893_CR36","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1186\/s13063-022-06747-2","volume":"23","author":"L Morris","year":"2022","unstructured":"Morris L, Dumville J, Treweek S, Miah N, Curtis F, Bower P. Evaluating a tool to improve engagement and recruitment of under-served groups in trials. Trials. 2022;23(1):867.","journal-title":"Trials"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08893-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-08893-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08893-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T11:30:52Z","timestamp":1750505452000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-08893-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8893"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-08893-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required for this audit.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RB, LG and LH work in the Nuffield Department of Primary Care Health Sciences, within which the PC-CTU is based; LG and LH work closely with the PC-CTU. MCa works in the PC-CTU.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"219"}}